Health innovation networks to help developing countries address neglected diseases

被引:125
作者
Morel, CM
Acharya, T
Broun, D
Dang, AJ
Elias, C
Ganguly, NK
Gardner, CA
Gupta, RK
Haycock, J
Heher, AD
Hotez, PJ
Kettler, HE
Keusch, GT
Krattiger, AF
Kreutz, FT
Lall, S
Lee, K
Mahoney, R
Martinez-Palomo, A
Mashelkar, RA
Matlin, SA
Mzimba, M
Oehler, J
Ridley, RG
Pramilla, S
Singer, P
Yun, MY
机构
[1] Fiocruz MS, Ctr Technol Dev Hlth, BR-21040900 Rio De Janeiro, Brazil
[2] Joint United Nations Programme HIV AIDS, New Delhi 110003, India
[3] Org Pharmaceut Producers India, Peninsula Chambers, Bombay 400013, Maharashtra, India
[4] Program Appropriate Technol Hlth, Seattle, WA 98107 USA
[5] Indian Council Med Res, New Delhi 110029, India
[6] Rockefeller Fdn, New York, NY 10018 USA
[7] CSIR, Intellectual Property Management Div, New Delhi 110067, India
[8] Mission United Kingdon United Nations, New York, NY 10017 USA
[9] Univ Cape Town, Res & Innovat House, ZA-7701 Cape Town, South Africa
[10] George Washington Univ, Dept Microbiol & Trop Med, Washington, DC 20037 USA
[11] Bill & Melinda Gates Fdn, Seattle, WA 98102 USA
[12] Boston Univ, Boston, MA 02118 USA
[13] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA
[14] Univ Fed Rio Grande do Sul, FK Biotecnol, BR-91501970 Porto Alegre, RS, Brazil
[15] Univ Oxford, Oxford OX1 3LA, England
[16] Seoul Natl Univ, Dept Econ, Seoul 151742, South Korea
[17] Minist Hlth, Mexico City 01900, DF, Mexico
[18] CSIR, New Delhi 110001, India
[19] Global Forum Hlth Res, CH-1211 Geneva, Switzerland
[20] S African Embassy, Dept Sci & Technol, B-1040 Brussels, Belgium
[21] Concept Fdn, Klongluang 12120, Pathumthani, Thailand
[22] WHO, Trop Dis Res Program, CH-1211 Geneva, Switzerland
[23] Global Forum Hlth Res, Colombo 2, Sri Lanka
[24] Univ Toronto, Toronto, ON M5G 1L4, Canada
[25] Korea Inst Int Econ Policy, Seoul 137747, South Korea
关键词
D O I
10.1126/science.1115538
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Gross inequities in disease burden between developed and developing countries are now the subject of intense global attention. Public and private donors have marshaled resources and created organizational structures to accelerate the development of new health products and to procure and distribute drugs and vaccines for the poor. Despite these encouraging efforts directed primarily from and funded by industrialized countries, sufficiency and sustainability remain enormous challenges because of the sheer magnitude of the problem. Here we highlight a complementary and increasingly important means to improve health equity: the growing ability of some developing countries to undertake health innovation.
引用
收藏
页码:401 / 404
页数:4
相关论文
共 26 条
[11]  
LEVI GC, 2002, J ACQ IMMUN DEF SYND, V16, P2373
[12]  
MASHELKAR RA, UNPUB
[13]  
*MEX STAT HLTH RES, STRENGTH HLTH SYST
[14]  
*MIN HLTH BRAZ, SCAL INT RESP AIDS B
[15]  
MOREL C, 2005, INNOVATION STRATEGY, V1, P1
[16]  
*ORG PHARM PROD IN, 2003, OUTS OPP IND PHARM I, P24
[17]   National Health Innovation System: relations between scientific fields and economic sectors [J].
Pereira, JCR ;
Baltar, VT ;
de Mello, DL .
REVISTA DE SAUDE PUBLICA, 2004, 38 (01) :1-8
[18]  
Prahalad C. K., 2004, FORTUNE BOTTOM PYRAM
[19]  
SAHA R, 2004, IP STRATEGY TODAY, V9, P23
[20]  
THORSTEINSDOTTI.H, COMMUNICATION